Your views
Your feedback is vital to us as we continue to increase the quality of our services.
You are here:
Date: 21 May 2012
Time: 16:39
Gastroenterology quality indicator
Percentage of patients admitted with inflammatory bowel disease (IBD) who received low molecular weight (LMW) heparin during their admission
What is inflammatory bowel disease?
IBD includes the conditions Crohn’s disease and ulcerative colitis. These diseases of the bowel can cause abdominal pain, diarrhoea and bleeding. These are relapsing conditions with periods when patients are well and other times when the disease flares up.
The majority of IBD patients are treated as outpatients although some patients will be admitted to hospital when their disease flares up. More information on IBD is available in the external links block.
How is the Trust doing?
| Rolling year to date (January 2011 – December 2011) | 92.2% |
|---|---|
| Rolling 2 years (January 2010 – December 2011) | 92.9% |
Lower percentage indicates better performance.
The Trust is performing consistently well against this indicator. Performance will continue to be monitored to ensure it remains high.
Why is this indicator important?
Patients with inflammatory bowel disease have an increased risk of developing blood clots. When patients are admitted to hospital the risk of blood clots is further increased due to bed rest.
There is some evidence that heparin medication is a useful treatment in IBD and very good evidence that heparin helps to prevent blood clots. We therefore think it is sensible to try to prevent blood clots developing in patients admitted to hospital due to their inflammatory bowel disease.
How do we measure this indicator?
The indicator is measured by the percentage of patients admitted to hospital with IBD who were prescribed low molecular weight heparin (Enoxaparin or Clexane) during their admission. This indicator looks at patients who were under the care of a gastroenterologist with a stay of greater than 72 hours in hospital.
Where does the data come from?
The data for this indicator is compiled from the Trust’s patient administration system called Lorenzo and the Prescribing and Information Communication System (PICS).
University Hospitals Birmingham NHS Foundation Trust is not responsible for the contents or the reliability of external websites and does not necessarily endorse the views expressed within them. Listing should not be taken as endorsement of any kind. We cannot guarantee that links to other websites will work all of the time, and we have no control over the availability of external web pages.
Related pages
Getting here
Information about travelling to, staying at and getting around the hospital.
Jobs at UHB
A great place to work. Learn Why.
